[MYGN] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 471.43%
YoY- -91.90%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 186,300 215,400 216,600 216,800 202,300 200,900 193,500 -2.49%
PBT -22,300 -7,700 3,300 3,600 800 16,100 16,500 -
Tax -1,700 -3,400 -3,600 1,000 1,600 3,000 5,200 -
NP -20,600 -4,200 6,900 2,600 -700 13,100 11,400 -
Tax Rate - - 109.09% -27.78% -200.00% -18.63% -31.52% -
Total Cost 206,900 219,600 209,700 214,200 203,000 187,800 182,100 8.87%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -11.06 -1.95 3.19 1.20 -0.35 6.52 5.89 -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -0.28 -0.06 0.09 0.04 -0.01 0.19 0.16 -
EPS Diluted -0.28 -0.06 0.09 0.03 -0.01 0.18 0.16 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.